Cubist Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released
 |
|---|
| companiesandmarkets.com |
2009-11-10 00:35:03 -
Cubist Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/cubist-pharm ..
Cubist Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Cubist Pharmaceuticals, Inc., a biopharmaceutical company is engaged in the research, development and commercialization of drug products for the acute care environments. The companys lead product, CUBICIN (daptomycin for injection), an intravenous, or I.V., antibiotic, developed and launched in the US accounted for majority of its revenues. CUBICIN is
used in the treatment of complicated skin and skin structure infections, blood-stream infections and right-sided infective endocarditis.
The Cubist Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
